Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
106.06
-7.28 (-6.42%)
At close: Jan 15, 2026, 4:00 PM EST
106.11
+0.05 (0.05%)
Pre-market: Jan 16, 2026, 5:32 AM EST
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $7.08 billion as of January 16, 2026. Its market cap has increased by 104.42% in one year.
Market Cap
7.08B
Enterprise Value
6.78B
1-Year Change
104.42%
Ranking
Category
Stock Price
$106.06
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $7.08B, an increase of 769.64%. That is a compound annual growth rate of 29.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 7.08B | -0.92% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |